A Glimpse Into the World of Metage­nomics

This com­men­tary was sub­mit­ted to us in re­sponse to our post, Fine Read­ing: Metage­nomics, pub­lished on Oc­to­ber 16, 2008. The ar­ti­cle en­ti­tled Metage­nomics that re­cently ap­peared in Na­ture pro­vides in­ter­est­ing in­sights into how metage­nomi­cists ap­pear to view mi­crobes and the field of mi­cro­bial ecol­ogy. What are some of the as­sump­tions that are be­ing made, based on the in­for­ma­tion given in this ar­ti­cle?

by Don­ald A. Klein

Metage­nomic ap­proaches ap­par­ently are as­sumed to be the only way to study mi­crobes in na­ture. It is as­serted that, due to the lim­i­ta­tions of cul­ti­va­tion-based ap­proaches (the "cul­tivation bot­tle­neck"), we have been ig­no­rant of their [mi­crobes']ex­is­tence. My sug­ges­tion? An ef­fec­tive and di­rect means of es­tab­lish­ing the ex­is­tence of most mi­crobes would be to use a mi­cro­scope. To­day, mi­croscopy, es­pe­cially when com­bined with stain­ing, en­zy­matic, im­muno­log­i­cal, and mol­e­c­u­lar tech­niques, pro­vides unique win­dows into mor­pho­log­i­cal, phys­i­o­log­i­cal, mol­e­c­u­lar, and im­muno­log­i­cal char­ac­ter­is­tics of mi­crobes as they ex­ist in situ.

In situ ac­tiv­ity of fil­a­men­tous fungi in soil is as­sessed us­ing flu­o­res­cein di­ac­etate (FDA) stain­ing. In this free hy­phal unit, only the FDA-pos­i­tive hy­phal re­gions con­tain ac­tive cy­to­plasm. Hy­phal di­am­e­ter = ~3–5 μm.

As an ex­am­ple from my own work, we have sought to as­sess in situ ac­tive fil­a­men­tous fungi in soils. The com­par­i­son of FDA-ac­tive (flu­o­res­cein di­ace­­tate-ac­tive) hy­phal lengths with to­tal hy­phal lengths pro­vides an es­ti­mate of the rel­a­tive ac­tive fun­gal hy­phal pres­ence, im­por­tant for char­ac­ter­iz­ing these in­de­ter­mi­nate fil­a­men­tous fungi and their respon­ses in var­i­ous ecosys­tems. Mi­croscopy-based ap­proaches are cen­tral to mi­cro­bial ecol­ogy, the study of in situ mi­cro­bial in­ter­ac­tions with their bi­otic and abi­otic en­vi­ron­ments.

What does it mean to state that metage­nomic ap­proaches can be used to study mi­cro­bial communi­ties? "Mi­cro­bial" in­cludes bac­te­ria, ar­chaea, fungi, al­gae, and pro­to­zoa, as well as the acel­lu­lar viruses, vi­roids, and pri­ons. More prob­lem­atic is the use here of the word "com­mu­nity." Based on its et­y­mol­ogy, to be part of a com­mu­nity, an or­gan­ism must be ac­tive and in­ter­act­ing in situ. It sim­ply is not ap­pro­pri­ate to as­sume that all mi­crobes in an en­vi­ron­ment (ac­tive, in­ac­tive, dead) are part of the "com­mu­nity."

The au­thors sug­gest that metage­nomics us­ing bulk-ex­tracted nu­cleic acids can pro­vide infor­mation on the genome se­quences of a com­mu­nity of or­gan­isms in­hab­it­ing a com­mon envi­ronment. How­ever, when us­ing bulk ex­trac­tion-based ap­proaches, one has no idea of the source(s) of the nu­cleic acids/gene se­quences that are be­ing stud­ied. It is not known if the re­cov­ered se­quences are de­rived from ac­tive mi­crobes, or even from mi­crobes. How to solve this prob­lem? Be sure the nu­cleic acids are de­rived from mi­cro­bial as­sem­blages that can be doc­u­mented to be ac­tive in situ, as in a re­cent study of Alvinella bac­te­r­ial episym­bionts. Fur­ther­more, as dis­cussed by Kowalchuk and col­leagues, am­pli­fi­ca­tion tech­nolo­gies pro­vide ac­cess to mi­cro­bial genomes at the level of a sin­gle mi­cro­bial cell, which presents the pos­si­bil­ity of ex­am­in­ing mi­cro­bial com­mu­nity genomes and ac­tiv­i­ties one cell at a time. This en­ables one to as­sess ge­netic mi­cro­hetero­gene­ity at the level of the in­di­vid­ual in situ ac­tive mi­crobe.

The pa­per notes that a strength of the metage­nomic ap­proach is its po­ten­tial for serendipi­tous dis­cov­ery. In­deed, this strength is most clearly demon­strated when the dis­cov­ered genes (such as those for ar­chaeal am­mo­nium ox­i­da­tion and pro­te­orhodopsins) can then be linked to or­gan­isms found in spe­cific environ­ments.

An over­all as­sess­ment? The field of metage­nomics can pro­vide new and ex­cit­ing views of mi­crobes and their eco­log­i­cal in­ter­ac­tions. The chal­lenge is to link this metage­nomic in­for­ma­tion to mi­crobes that are ac­tive in situ. With this link­age, the metage­nomic ap­proach will more ef­fec­tively ful­fill its po­ten­tial for pro­vid­ing new and truly ex­cit­ing in­for­ma­tion con­cern­ing mi­cro­bial ecol­ogy, i.e., the study of in situ ac­tive mi­crobes and their in­ter­ac­tions with their bi­otic and abi­otic en­vi­ron­ments.

 

Donald A. Klein

Don­ald A. Klein is a pro­fes­sor in the De­part­ment of Mi­cro­bi­ol­ogy, Im­munol­ogy, and Pathol­ogy, Col­lege of Vet­eri­nary Med­i­cine and Bio­med­ical Sci­ences, Colora­do State Uni­ver­sity. A more de­tailed ver­sion of Don's views was pub­lished in the De­cem­ber, 2007, is­sue of ASM's Mi­crobe mag­a­zine.

 

Other Posts

2 Comments
Oldest
Newest Most Voted
R. G. E. Murray
17 years ago

I agree strongly that the metage­nomic ap­proach can be interp[eted over-con­fi­dently in the study of com­plex com­mu­ni­ties. The points are well made. How­ever, I think one should add that the spec­tre on "un­cul­ti­vata­bil­ity" should not de­ter at­tempts to en­rich or fur­ther cul­ti­vate the poses­sor of an un­usual but phys­i­o­log­i­cally re­lat­able mi­crobe be­cause the se­quence has given clues as where one might start to ring the changes in pro­vid­ing pos­si­ble con­di­tions. There should be ap­pre­ci­a­tion of the ad­vice by Howard Gest: The mi­crobe is grow­ing in its en­vi­ron­ment where there are suit­able con­di­tions for growth and these con­di­tions have to be dis­cov­ered.

Poonam Agarwal
17 years ago

For a metage­nomic ap­proach, is it pos­si­ble to ob­tain the non-cul­tur­able mi­cro­bial flora in dis­eased plant leaves sam­ple ex­clud­ing the plant ge­nomic DNA ex­trac­tion?